NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Cardiovascular Medicine > Oxford to play key role in two new MRC gene therapy centres

Oxford to play key role in two new MRC gene therapy centres

11 December 2024 · Listed under Cardiovascular Medicine, Gene and Cell Therapy, Genomic Medicine

The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these centres and co-leading the other. Together, these international collaborations will receive up to £50 million each over 14 years.

The centres will build on the huge progress that has been made in genomics – allowing the genetic basis of many diseases and processes to be identified – and advances in genome editing and other gene therapies, which have made it possible to develop treatments for previously incurable conditions.

The centres will take different approaches to translating the advances in genomics into therapies to treat many diseases, such as heart disease, severe immune disorders, genetic causes of blindness, many developmental disorders that affect children, including those that cause severe seizures in babies, and neurodegenerative conditions such as Huntingdon’s disease.

One centre, called the MRC/BHF Centre of Research Excellence in Advanced Cardiac Therapies, will be co-funded with the British Heart Foundation (BHF) and will focus on developing gene therapies for heart disease.

The other centre, called the MRC Centre of Research Excellence in Therapeutic Genomics, aims to make rare genetic disorders treatable by enabling the mass production of affordable cutting-edge gene therapies.

Oxford institutions involved in the new Centres include the Institute of Developmental and Regenerative Medicine (IDRM), the Department of Paediatrics, the Department of Physiology, Anatomy and Genetics (DPAG), the Nuffield Department of Clinical Neurosciences (NDCN)  and the Radcliffe Department of Medicine.

The MRC’s new CoRE funding model aims to transform biomedical and health research by revolutionising approaches to prevention, early detection, diagnosis and treatment of diseases by bringing together the very best researchers to tackle the challenge, wherever they are based. In addition, the centres will be beacons of excellence driving positive changes in research culture, and in training the next generation of pioneers in the field.

Much of this research overlaps with that being conducted in the NIHR Oxford Biomedical Research Centre’s Themes.

A number of the Oxford BRC’s patient and public involvement participants were involved in developing the bid for the MRC CoRE in Therapeutic Genomics, and ensuring that it meets the needs of patients.

Read more about the new MRC Centres of Research Excellence.

← Oxford professor named among world’s top 100 ophthalmologists
Blood test developed to allow early detection of multiple cancers →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre